Navigation Links
Immune Therapy May Aid Kids With Neuroblastoma
Date:5/14/2009

Researchers praise new treatment for deadly cancer,,

THURSDAY, May 14 (HealthDay News) -- In a phase 3 clinical trial, an experimental immune-based treatment boosted by 20 percent the overall survival of those with tough-to-treat neuroblastoma, which affects mostly children.

The findings are to be presented at the American Society for Clinical Oncology annual meeting, which starts later this month in Florida.

The trial involved 226 patients newly diagnosed with high-risk neuroblastoma, a cancer of the nervous system. Standard treatment includes surgery, aggressive chemotherapy with "stem cell rescue" (where the patient's stem cells are removed before treatment, then returned after chemotherapy to boost blood/immune function) and radiation therapy.

"Even though we treat it with aggressive therapy, high-risk neuroblastoma often returns, and most patients do not survive," Dr. Alice Yu, a professor of hematology/oncology at the University of California, San Diego, and the school's Moores Cancer Center, said in a news release from the society.

The new immune-based treatment -- called chimeric anti-GD2 antibody ch14.18 -- targets a key sugar-and-fat molecule lying on neuroblastoma cells called GD2. Left alone, the molecule inhibits the immune system from attacking the cancer cells. But the new antibody binds to GD2, encouraging such attacks, the researchers explained.

In the new trial, half of the patients received chemotherapy/stem cell rescue plus standard treatment (retinoic acid), as well as the new immunotherapy. The others received standard treatment only.

After two years, the number of participants who had survived without a relapse reached 66 percent in the immunotherapy groups, compared with 46 percent among those who did not get the new treatment. Overall survival after two years reached 86 percent in the immunotherapy cohort and 75 percent among those who got standard treatment.

"It is very exciting to have a new treatment option for this disease," Yu said, "and we hope to make this immunotherapy available to more children with neuroblastoma."

The study is to be presented June 2 at the meeting but was described in a news conference Thursday.

More information

The University of Chicago has more on neuroblastoma in children.



-- E.J. Mundell



SOURCE: American Society of Clinical Oncology, news release, May 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Immune exhaustion driven by antigen in chronic viral infection
2. Scientists develop mathematical model to predict the immune response to influenza
3. Scientists discover how smallpox may derail human immune system
4. Immune Deficiency Foundation Honors Cerda Family and Volunteers From ABCs Extreme Makeover: Home Edition
5. Researcher IDs Narcolepsy as Autoimmune Disease
6. Narcolepsy is an autoimmune disorder, Stanford researcher says
7. 7 Top Rated Immune Support Products from Swanson Vitamins
8. Ingredient in Probiotic Sweetener Boosts Immune System
9. Scientists discover how to improve immune response to cancer at Princess Margaret Hospital
10. New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin
11. Instead of fighting breast cancer, immune cell promotes its spread
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune Therapy May Aid Kids With Neuroblastoma
(Date:4/30/2016)... Jamaica (PRWEB) , ... April 30, 2016 , ... ... and Duane Boise, President and CEO of EMED, today signed a multifaceted agreement ... , EMED and the Northern Caribbean University Department of Natural and Applied Sciences, ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... April 4th, 2016 questioned the use of the HyProCure sinus tarsi implant. ... controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, when indicated, to ...
(Date:4/30/2016)... ... ... a challenge for all of us, but there are things we can do to improve the ... is showing more and more that there are simple, yet important steps that can be taken ... priorities Dr. Kohli’s recommends for her patients include;, , exercise , ...
(Date:4/30/2016)... ... , ... Orlando-based Maximized Living has selected Dr. Nick Wilson of Indianapolis to ... the care of Maximized Living doctors at the London Olympics in 2012, U.S. wrestlers ... sending the largest contingent of elite chiropractors to Rio to support and care for ...
(Date:4/29/2016)... FL (PRWEB) , ... April 30, 2016 , ... ... and engineer of patented products, announces the Pick Up Springboard, an automotive invention ... and Light Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Tie-up with Government ... to save newborns   Fortis La ... newborns in collaboration with Breast Milk Foundation (BMF), a non-profit ... Human Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit centre ... for infants and should be available to babies deprived of ...
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/26/2016)... 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) is ... , Pharm D., to Vice President of Education and ... Hagerman will continue to lead and oversee Diplomat University, ... education and training to Diplomat employees and external professionals ... University also houses the quality assurance department, which focuses ...
Breaking Medicine Technology: